Institute for Immunology, Center for Diagnostics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Department of Obstetrics and Fetal Medicine, Laboratory for Experimental, Feto-Maternal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Am J Reprod Immunol. 2019 Feb;81(2):e13084. doi: 10.1111/aji.13084. Epub 2019 Jan 28.
Steroid hormones such as progesterone and glucocorticoids rise during pregnancy and are accountable for the adaptation of the maternal immune system to pregnancy. How steroid hormones induce fetal tolerance is not fully understood. We hypothesized that steroid hormones selectively regulate the T-cell response by promoting T-cell death.
We incubated murine spleen cells isolated from non-pregnant and pregnant mice with physiological concentrations of steroid hormones in vitro and analyzed T-cell subsets after 48 h of incubation. Results We found that progesterone and the synthetic glucocorticoid dexamethasone induce T-cell death. CD4 regulatory T (T ) cells were refractory toward progesterone-induced cell death, in contrast to conventional CD4 T cells, which resulted in a preferential enrichment of CD4 T cells in culture. T cells isolated from pregnant mice at early and late gestation showed comparable sensitivity to steroid-induced cell death. The target receptor for progesterone in immune cells is controversially discussed. We provide here support of progesterone binding to the glucocorticoid receptor as only T cells lacking the glucocorticoid but not the progesterone receptor showed resistance against progesterone-induced death. Conclusions Our results indicate that high levels of progesterone during pregnancy can induce selective T-cell death by binding the glucocorticoid receptor. Although physiological hormone concentrations were used, due to different bioavailability of steroid hormones in vivo these results have to be validated in an in vivo model. This mechanism might ensure immunological tolerance at the feto-maternal interface at gestation.
甾体激素(如孕激素和糖皮质激素)在妊娠期间升高,是母体免疫系统适应妊娠的原因。甾体激素如何诱导胎儿耐受尚未完全阐明。我们假设甾体激素通过促进 T 细胞死亡来选择性地调节 T 细胞反应。
我们将来自非妊娠和妊娠小鼠的脾细胞在体外与生理浓度的甾体激素孵育 48 小时,分析孵育后 T 细胞亚群。
我们发现孕激素和合成的糖皮质激素地塞米松诱导 T 细胞死亡。与传统的 CD4 T 细胞不同,CD4 调节性 T(Treg)细胞对孕激素诱导的细胞死亡具有抗性,导致培养物中 CD4 T 细胞的优先富集。从妊娠早期和晚期的妊娠小鼠中分离的 T 细胞对类固醇诱导的细胞死亡具有相似的敏感性。免疫细胞中孕激素的靶受体存在争议。我们在此提供孕激素与糖皮质激素受体结合的证据,因为只有缺乏糖皮质激素而不是孕激素受体的 T 细胞对孕激素诱导的死亡具有抗性。
我们的结果表明,妊娠期间高水平的孕激素通过结合糖皮质激素受体可诱导选择性 T 细胞死亡。尽管使用了生理激素浓度,但由于体内甾体激素的生物利用度不同,这些结果需要在体内模型中验证。这种机制可能确保妊娠时胎-母体界面的免疫耐受。